Skip to main content
NCD 160.1 · version 1

NCD 160.1: Induced Lesions of Nerve Tracts

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database NCDs: API snapshot September 27, 2026 (effective September 20, 2026). Next CMS release: weekly, every Thursday.

Medicare Coverage Database NCDs: the loaded version is API snapshot September 27, 2026, and the CMS schedule called for a newer one from October 1, 2026. Verify figures against the current CMS publication until this reference is rebuilt; pages built on it are withdrawn from search indexing until then.

Key facts for NCD 160.1

Benefit category
Physicians' Services
Effective date
Longstanding NCD
Date of this version not posted by CMS
Transmittal
n/a
Versions published
1
Manual section
160
Nervous System, NCD Manual (Pub. 100-03) chapter 1 part 2

TL;DR

NCD 160.1 sets Medicare's national policy for induced lesions of nerve tracts under the benefit category "Physicians' Services", as a longstanding NCD (CMS has not posted the effective date of its current version). Surgically induced lesions of nerve tracts which involve destruction of nerve tissue are primarily indicated for controlling the chronic or acute pain arising from conditions such as terminal cancer or lumbar degenerative arthritis. Induced lesions of nerve… It has been revised once since publication and binds every Medicare Administrative Contractor nationally.

Indications and limitations of coverage

Surgically induced lesions of nerve tracts which involve destruction of nerve tissue are primarily indicated for controlling the chronic or acute pain arising from conditions such as terminal cancer or lumbar degenerative arthritis. Induced lesions of nerve tracts may be produced by surgical cutting of the nerve (rhizolysis), chemical destruction of the nerve, or by creation of a radio-frequency lesion (electrocautery). Accordingly, program payment may be made for these denervation procedures when used in selected cases (concurred in by the Medicare Administrative Contractor’s medical staff) to treat chronic pain.

Note that these procedures differ from those employing implanted electrodes and associated equipment to control pain in that the nerve fibers are ablated rather than stimulated and no electronic equipment is required by the patient after the operation.

Text reproduced from the CMS Medicare Coverage Database record for NCD 160.1 version 1. View the original on cms.gov.

How this NCD shows up on remittances

A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.

Prior authorization in Original Medicare

  • WISeR model prior authorization or pre-payment review in Arizona, New Jersey, Ohio, Oklahoma, Texas and Washington for services on or after January 15, 2026; the model runs through December 31, 2031. CMS service group: Induced Lesions of Nerve Tracts. Codes on the CMS list: 64605 and 64610.

Medicare Advantage plans run their own prior authorization lists. See the WISeR services and codes for this NCD.

For teams evaluating QuickIntell software

Evaluate a coverage-review workflow around NCD 160.1

Explore QuickAuth for requirement checks, documentation preparation and status tracking with staff oversight. Bring the policy-review steps your team repeats to a scoped evaluation, and confirm plan-specific requirements and supported actions. Use QuickRCM to evaluate the separate claim and denial workflow; a published NCD is not an authorization or payment guarantee.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — NCD 160.1

What does NCD 160.1 cover?

Surgically induced lesions of nerve tracts which involve destruction of nerve tissue are primarily indicated for controlling the chronic or acute pain arising from conditions such as terminal cancer or lumbar degenerative arthritis. Induced lesions of nerve tracts may be produced by surgical cutting of the nerve (rhizolysis), chemical destruction of the nerve, or by creation of a radio-frequency lesion… The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.

When did NCD 160.1 take effect?

NCD 160.1 is a longstanding NCD (CMS has not posted the effective date of its current version); the current version is 1. This is the only published version.

Does a Local Coverage Determination override NCD 160.1?

No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.